Form4insider filings, from the source

SEC Form 4 · accession 0001225208-17-003259

JOHNSON & JOHNSON · JNJ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Joaquin Duato
Officer — Exec VP, WW Chair, Pharma
Period of report
Feb 10, 2017
Accepted (ET)
Feb 14, 2017 · 5:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000200406

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 10, 2017M8,919$0.00A56,879D
Common StockF2Feb 10, 2017F3,363$115.13D53,516D
Common StockF3holding———560IBy 401k

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Share UnitsF1—Feb 10, 2017M8,919DFeb 10, 2017—Common Stock8,9190D

Explanation of responses